Status:
COMPLETED
Pharmacological Profile of Different Berberine Formulations, and Effects on Blood Sugar Levels
Lead Sponsor:
Factors Group of Nutritional Companies Inc.
Conditions:
Pharmacokinetics
Eligibility:
All Genders
21-65 years
Phase:
NA
Brief Summary
The primary objective of this study is to evaluate the gastrointestinal absorption of berberine (hydrochloride) in a novel formulation in healthy adult volunteers by comparing it with free berberine (...
Eligibility Criteria
Inclusion
- Age 21-65
- healthy, good physical condition
Exclusion
- Pregnancy or breast-feeding
- Gastrointestinal conditions
- Acute or chronic liver disease
- Acute or chronic kidney disease
- Acute or chronic cardiovascular disease
- Hematological disease
- Diabetes
- Allergy or Intolerance to gluten
- Allergy or Intolerance to Berberine
- Use of any form of nicotine or tobacco
- Alcohol and substance abuse history
- Use of medications (e.g., blood sugar-lowering agents, or statins)
- Use of Berberine supplements
- Participation in another investigational study
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 4 2022
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT05370261
Start Date
February 1 2022
End Date
May 4 2022
Last Update
February 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ISURA
Burnaby, British Columbia, Canada, V3N4S9